Mental health
0The government has announced an expansion to and fresh payment structure for the new medicine service (NMS) to “boost mental health support in the community”.
0A new study has revealed that the use of GLP-1RAs such as semaglutide are “not associated” with an increased risk of suicidality among patients with type 2 diabetes.
0The National Institute for Health and Care Excellence (NICE) has proposed that people with long-term conditions – including obstructive sleep apnoea, schizophrenia and learning disabilities – are weighed annually.
1A coroner has warned of the “potential dangers” of a trio of drugs, after a patient died who had been on them for four years “without concern”.
0A coroner has warned that the lack of “communication between primary and secondary care” may lead to the “early death” of more patients, after an NHS trust was not made aware of a pharmacy’s warning.
0NHS England (NHSE) has launched a “confidential 24/7 text support service” for pharmacists who are feeling “worried or overwhelmed” and need someone to speak to.
0The pharmacy regulator has advised that pharmacy teams carry out a “robust” assessment before supplying finasteride – a hair-loss drug with psychiatric and sexual health risks.
0A “thorough review” by the Medicines and Healthcare products Regulatory Agency (MHRA) has found that evidence “does not support” a link between suicidal ideation and diabetes and weight management drug semaglutide.
0A pharmacist independent prescriber has been removed from the GPhC register after issuing tens of thousands of prescriptions using online questionnaires.
0GP bureaucracy can leave individuals “without access to medication, which could cause or contribute to their death”, a coroner has warned.